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A B S T R A C T
We report the ﬁrst published case of acute pancreatitis secondary to disseminated nocardiosis in a hematopoietic
stem cell transplant (HSCT) recipient on chronic immunosuppression for graft-versus-host disease (GVHD).
Nocardiosis in the HSCT population is relatively rare, and has not yet been described in haploidentical HSCT
recipients. Our patient is a 28-year-old male with a history of haploidentical HSCT and GVHD of the skin and
lung who was admitted to the hospital with acute pancreatitis. The workup for the etiology of his pancreatitis
was initially unrevealing. He subsequently developed worsening sepsis and respiratory failure despite broad
spectrum antimicrobials. After multiple bronchoscopies and pancreatic ﬂuid sampling, he was found to have
disseminated nocardiosis with Nocardia cyriacigeorgia.
Introduction
Nocardia spp. is an aerobic gram-positive ﬁlamentous branching
bacterium that is an uncommon cause of opportunistic infections in
patients receiving hematopoietic stem cell transplantation (HSCT).
While the incidence of nocardiosis in the allogeneic HSCT population is
unclear, it is estimated around 0.3 to 1.7% according to two studies in
the 1990s [1,2]. Risk factors for infection include immunosuppression
for chronic GVHD and use of inhaled pentamidine for pneumocystis
prophylaxis [3].
Nocardia can be found throughout the environment, including in
water and soil. Due to its ability to aerosolize, it commonly causes a
primary pulmonary infection, with a majority of patients presenting
with fever, cough, and pleuritic chest pain [4]. However, Nocardia can
disseminate to other organs, particularly the skin and central nervous
system. Nocardial infection of the pancreas has been reported in an
immunocompetent patient who had a resection and radiotherapy for
bladder cancer [5]. We report the ﬁrst published case of acute pan-
creatitis secondary to disseminated nocardiosis in a HSCT recipient on
chronic immunosuppression for GVHD.
Patient presentation
The patient is a 28-year-old male who was diagnosed with acute
myelogenous leukemia after presenting with fevers and chills. He un-
derwent induction chemotherapy on clinical trial with cytarabine,
idarubicin and sirolimus, and subsequent consolidation therapy with
high-dose cytarabine. After achieving complete remission, he under-
went a haploidentical HSCT from his mother. His conditioning regimen
consisted of high-dose total body irradiation and cyclophosphamide.
His transplant course was complicated by neutropenic fevers without
positive cultures and skin GVHD. He was discharged on tacrolimus,
mycophenolate mofetil and high-dose prednisone. His prophylactic
antimicrobials included penicillin VK, valacyclovir, voriconazole and
inhaled pentamidine every four weeks, due to a sulfonamide allergy.
His post-transplant course was unfortunately complicated by staphy-
lococcal bacteremia and pneumonia, inﬂuenza and respiratory syncy-
tial viral infections and pseudomonas sinusitis requiring debridement.
In addition to skin GVHD, he also developed pulmonary GVHD con-
ﬁrmed by video assisted thoracic surgery (VATS) biopsy 10 months
after his HSCT. The biopsy was negative for aerobic, anaerobic, fungal
and acid-fast bacilli (AFB) cultures.
The patient then presented in October, two years after his trans-
plant, with fevers and abdominal pain. At that point, he was on
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dexamethasone 6 mg daily and ruxolitinib 5 mg twice daily for his
pulmonary GVHD, and inhaled budesonide and montelukast for his
chronic sinusitis. He had been previously on high-dose prednisone and
sirolimus, with multiple failed attempts at weaning. He was also on
prophylactic posaconazole, valacyclovir, atovaquone and azithromycin.
His listed allergies at time of admission were: amoxicillin causing rash,
vancomycin causing acute kidney injury, sulfonamide drugs causing
rash, and voriconazole causing transaminitis. He was diagnosed with
acute pancreatitis with an elevated lipase of 1204 units/l (normal range
13–60 units/l), though CT scan of the abdomen did not show any
peripancreatic inﬂammation.
Workup of the etiology of the pancreatitis was unrevealing. While
steroids are a known cause of pancreatitis, the patient had been on both
high dose prednisone and dexamethasone in the past without GI com-
plications. The patient denied alcohol use and abdominal ultrasound
was negative for cholelithiasis. He had normal triglyceride and calcium
levels, negative CMV titers, galactomannan, viral hepatitis serologies,
Epstein-Barr virus and adenovirus titers. Stool studies were also nega-
tive for infectious diarrheal pathogens. His initial CT scan of the chest
to evaluate his fevers showed multiple pulmonary nodules, which were
attributed to progression of chronic GVHD (Fig. 1: CT chest on hospital
day 4, showing multiple pulmonary nodules and tree-in-bud opacities).
He also had a CT of the abdomen that showed a nebulous, hypoatte-
nuating 1 cm lesion in the pancreatic body (Fig. 2: CT abdomen on
hospital day 4, with vague 1 cm lesion in pancreatic body).
Due to persistent fevers, he was started on linezolid and meropenem
in addition to his prophylactic antimicrobials. Shortly after, he under-
went bronchoscopy on hospital day 5, which showed grossly normal
airways. Cultures for bacteria, fungus and AFB were initially negative.
Bronchoalveolar lavage analysis showed predominantly macrophages,
without signs of malignancy, viral or fungal infection. Despite resolu-
tion of his abdominal pain and fevers, he had progressive respiratory
failure requiring intubation and presumed septic shock of unknown
origin.
On hospital day 12, he underwent a second bronchoscopy with both
lavage and transbronchial biopsies. His cultures were initially negative
although the transbronchial biopsy pathology demonstrated focal in-
terstitial and organizing pneumonia. His antibiotics were broadened by
adding amikacin and voriconazole. He was continued on high dose
steroids for refractory shock and chronic GVHD and initially showed
clinical improvement. His ﬁrst bronchoscopy cultures showed
Mycobacterium avium complex (MAC). However, given that no
subsequent cultures were positive and he clinically improved, this was
thought to be due to colonization.
On hospital day 20, he developed another episode of acute ab-
dominal pain. Repeat CT of the abdomen showed a new pancreatic tail
ﬂuid collection measuring 6 cm x 4.5 cm x 4.1 cm (Fig. 3: CT abdomen
on hospital day 20, showing worsening pancreatic collection). Repeat
CT of the chest to evaluate his persistent respiratory failure showed
progressively worsening pulmonary nodules with a miliary appearance.
The gastroenterology team evaluated the patient and thought his
abdominal CT scan was consistent with a simple pancreatic pseudocyst
related to his earlier pancreatitis. His lipase level was normal during
this episode and his symptoms resolved without intervention. After
being weaned oﬀ antibiotics and steroids, he developed recurrent ab-
dominal pain with severe guarding concerning for an acute abdomen.
On hospital day 25, a CT angiography of the abdomen was performed. It
did not show any mesenteric vascular occlusion but noted that the
pancreatic ﬂuid collection had become multi-lobed and enlarged in
size, measuring 13.8 cm × 7.2 cm× 6.8 cm. In addition, there was a
new intraperitoneal loculated collection near the liver (Fig. 4: CT
Fig. 1. CT chest on hospital day 4, showing multiple pulmonary nodules and tree-in-bud
opacities.
Fig. 2. CT abdomen on hospital day 4, with vague 1 cm lesion in pancreatic body.
Fig. 3. CT abdomen on hospital day 20, showing worsening pancreatic collection.
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abdomen on hospital day 25, showing worsening pancreatic collection
and new caudate lobe collection).
On hospital day 29, he underwent emergent percutaneous catheter
drainage of the pancreatic ﬂuid collection. Seven days later, pancreatic
ﬂuid cultures grew branching acid-fast Gram-positive bacilli concerning
for Nocardia. Concurrently, his prior bronchoscopy culture from hos-
pital day 12 grew out the same pathogen. Given the propensity for
nocardiosis to aﬀect the CNS, the patient had MRI scans of the brain
and complete spine, which showed multiple microabscesses aﬀecting
the brain and cervicothoracic spine (Fig. 5: MRI brain on hospital day
36, with punctate enhancing lesions and one notable ring-enhancing
lesion (T1 post contrast). The organism was eventually identiﬁed as
Nocardia cyriacigeorgia, with the following susceptibilities: sensitive to
trimethoprim-sulfamethoxazole (TMP-SMX), linezolid, amikacin, cef-
triaxone, doxycycline, minocycline and tobramycin; intermediate to
imipenem; resistant to ciproﬂoxacin, moxiﬂoxacin, amoxicillin-clavu-
lanate and clarithromycin. The patient was initially started on imi-
penem (which was narrowed to high-dose ceftriaxone after suscept-
ibilities became available), amikacin and TMP-SMX after
desensitization due to his sulfonamide allergy.
Discussion
Acute pancreatitis is a common medical diagnosis with several
etiologies, though the role of infectious agents is less well understood.
Most common infectious etiologies of pancreatitis are viruses, including
herpesviruses, viral hepatitis, enteroviruses and HIV, as well as parasite
infections such as ascariasis. While the incidence of various infectious
causes has not been determined, a 1996 case review showed that a
minority of cases reported were bacterial in origin, and out of those,
few had positive pancreatic tissue or ﬂuid cultures [6].
This is a rare case of disseminated nocardiosis presenting as acute
pancreatitis. Our patient presented with pancreatitis 2 years post HSCT
in the setting of chronic immunosuppressive treatment for GVHD. His
initial work up did not identify a cause of acute pancreatitis.
Unfortunately, it was only after a prolonged hospital stay with multiple
imaging and invasive studies that a deﬁnitive cause was elucidated. He
was initially treated empirically with linezolid and meropenem for fe-
vers and worsening lung inﬁltrates. Following a negative bronchoscopy,
he received increased immunosuppression for a presumed ﬂare of
pulmonary GVHD. He then developed recurrent abdominal pain and a
new pancreatic ﬂuid collection; aspirate of this ﬂuid identiﬁed Nocardia
on culture. Later, the second bronchoscopy turned positive for
Nocardia, conﬁrming a lung source of infection. Thus, his clinical pic-
ture was complicated by ongoing high-intensity immunosuppression,
diﬃculty interpreting his abnormal chest CT ﬁndings in the setting of
pulmonary GVHD, and intermittent treatment with broad spectrum
antibiotics active against Nocardia, which likely reduced the yield from
the bronchial aspirate cultures.
Management of disseminated nocardiosis can be diﬃcult because of
the variation of antibiotic susceptibilities among diﬀerent strains and
populations, as well as delay in accurate pathogen identiﬁcation and
susceptibilities. Additionally, patients on TMP-SMX prophylaxis are still
susceptible to Nocardia infection. A 2007 case-control study involving
solid organ transplant recipients showed that 69% of aﬀected patients
were on TMP-SMX prophylaxis three times weekly prior to infection
[8]. Standard therapy for nocardiosis depends on the degree of in-
volvement. Treatment for isolated cutaneous lesions can consist of
single-agent TMP-SMX, with alternative therapy based on sensitivities.
Treatment of severe infection consists of intravenous TMP-SMX or
imipenem, combined with amikacin. However, with evidence of CNS
involvement, all three antibiotics are preferred. Of note, our patient had
an allergy to TMP-SMX. Because of the long history of eﬀective treat-
ment with TMP-SMX and excellent widespread tissue penetration, in
patients with sulfonamide allergy, desensitization therapy is re-
commended while susceptibilities are pending. In a recent study of 132
cancer patients with nocardiosis in Texas, isolates remained highly
susceptible to TMP-SMX [9]. Interestingly, this patient’s Nocardia cy-
riacigeorgia isolate susceptibility pattern correlates with the isolates
from the above mentioned study, with almost all isolates resistant to
ﬂuoroquinolones and clarithromycin. However, the Centers for Disease
Control reported increasing resistance of Nocardia isolates to sulfona-
mide antibiotics between 1995 and 2004, with 61% of isolates resistant
to SMX and 42% resistant to TMP-SMX [10]. This highlights the high
degree of variability in antibiotic susceptibility depending on geo-
graphic location.
The adequate duration of therapy depends on the severity of illness.
Overall, there is a paucity of clinical trial data and recommendations
are based mostly on expert opinion. Most advocate for initial in-
travenous therapy for six weeks, with transition to oral therapy for a
total of at least three months of treatment [11]. However, with patients
requiring prolonged immunosuppression on treatment for viral co-in-
fection or with graft failure, disease management may require longer
courses of therapy. One retrospective study of 27 HSCT patients with
nocardiosis from 1969 to 1995 demonstrated survival rates of 66% at
Fig. 4. CT abdomen on hospital day 25, showing worsening pancreatic collection and
new caudate lobe collection.
Fig. 5. MRI brain on hospital day 36, with punctate enhancing lesions and one notable
ring-enhancing lesion (T1 post contrast).
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one year with a majority of patients receiving a sulfonamide-containing
regimen [1].
In summary, this is a unique case of disseminated nocardiosis pre-
senting as acute pancreatitis in an immunocompromised patient. Only
through extensive work up including invasive procedures to obtain
sampling of peripancreatic and bronchial ﬂuid was the organism iso-
lated. The patient was aggressively treated with a multidrug regimen
for severe disseminated disease until culture sensitivities were de-
termined, with initial clinical improvement. However, he suddenly
decompensated approximately 1 month after initiation of nocardial
antimicrobial therapy, was placed on comfort measures, and expired
shortly afterwards. Autopsy revealed widespread distribution of mi-
croabscesses in the kidneys, liver, lungs, spleen, heart (myocardium and
endocardium), mesentery and thyroid.
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